NEW APPROACHES TO THE THERAPY OF MILD HYPERTENSION

被引：33

作者：

KAPLAN, NM

机构：

来源：

AMERICAN JOURNAL OF CARDIOLOGY | 1983年 / 51卷 / 04期

关键词：

D O I：

10.1016/S0002-9149(83)80198-2

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：621 / 627

页数：7

相关论文

共 42 条

[1] MANAGEMENT OF THE HYPERTENSIVE PATIENT - A CONTINUING DILEMMA
ALDERMAN, MH
MADHAVAN, S
[J]. HYPERTENSION, 1981, 3 (02) : 192 - 197
[2] AMERY A, 1978, LANCET, V1, P681
[3] IMPROVEMENT OF GLUCOSE-TOLERANCE AND LOWERING OF GLYCOHEMOGLOBIN AND SERUM-LIPID CONCENTRATIONS AFTER DISCONTINUATION OF ANTIHYPERTENSIVE DRUG-THERAPY
AMES, RP
HILL, P
[J]. CIRCULATION, 1982, 65 (05) : 899 - 904
[4] EFFECTS OF TREATMENT ON MORBIDITY IN HYPERTENSION - RESULTS IN PATIENTS WITH DIASTOLIC BLOOD PRESSURES AVERAGING 115 THROUGH 129 MM HG
不详
[J]. JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1967, 202 (11): : 1028 - &
[5] [Anonymous], 1981, LANCET, V2, P539
[6] [Anonymous], 1980, LANCET, V1, P1261
[7] BERGLUND G, 1981, LANCET, V1, P744
[8] LABETALOL - REVIEW OF ITS PHARMACOLOGY AND THERAPEUTIC USE IN HYPERTENSION
BROGDEN, RN
HEEL, RC
SPEIGHT, TM
AVERY, GS
[J]. DRUGS, 1978, 15 (04) : 251 - 270
[9] ANTIHYPERTENSIVE BETA-BLOCKING ACTION AS RELATED TO RENIN AND AGE - PHARMACOLOGIC TOOL TO IDENTIFY PATHOGENETIC MECHANISMS IN ESSENTIAL HYPERTENSION
BUHLER, FR
BURKART, F
LUTOLD, BE
KUNG, M
MARBET, G
PFISTERER, M
[J]. AMERICAN JOURNAL OF CARDIOLOGY, 1975, 36 (05) : 653 - 669
[10] MULTIPLE RISK FACTOR INTERVENTION TRIAL (MRFIT) .6. INTERVENTION ON BLOOD-PRESSURE
COHEN, JD
GRIMM, RH
SMITH, WM
[J]. PREVENTIVE MEDICINE, 1981, 10 (04) : 501 - 518

← 1 2 3 4 5 →